FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2025
Back to search
Official data from USPTO
APTAR PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APTAR PHARMA
ST13
US500000079361471Class
8, 9, 17, 20, 35, 42, 44
Filing
79361471
Registration
7646295
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/03/2026
Trademark type
Word
Nice classes
8, 9, 17, 20, 35, 42, 44
Filing date
06/03/2022
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
HARMON, RAYMOND E
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
APTAR FRANCE SAS
Representatives
Ben Natter Haug Partners, LLP
Technical classification
Nice Classes
Class 8Class 9Class 17Class 20Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 8
Hand-operated pumps for ejecting medical and pharmaceutical preparations from receptacles and containers; Hand-operated hand tools and implementshand-operated pumps for ejecting medical and pharmaceutical preparations from receptacles and containers
Class 9
Downloadable and recorded software for monitoring health; Downloadable and recorded software for managingtracking and monitoring the taking of prescription medicationsmanagingtracking and monitoring healthcare treatments in the nature of injectable medicationsnasal medicationsdermally delivered medicationsrespiratory drugs for use in the medical field; downloadable and recorded software for reminding and delivering drug treatments to patients and providing information for schedulingreporting and monitoring treatment side effectsproviding educational contents and improving communication with their healthcare teams for medical use; data processing equipment
Class 17
Rubber lids and caps for industrial packaging containers; Rubber sealing elementsrubber seals for jarssealing plugs made primarily from rubberrubber bottle stoppers; rubber stoppers for bottles for medical use; rubber stoppers for bottles for medicine containers; rubber stoppers for bottles for use with medical pharmaceutical infusionsfor antibioticsfor conditioning of liquidsgasespowders and freeze-dried products; valves of synthetic rubber
Class 20
Plastic packaging components for medical packaging containers and for commercial packaging in the nature of dispensing and closable pour spouts and container and carton closures; Valves not of metalnon-metal valves for containers being aerosol dispensers for medical pharmaceutical use; Plastic containers for commercial packaging in the nature of bottlessqueeze tubesjarsspray pumps.
Class 35
Business to business wholesale ordering services for devices for medical use; business to business wholesale ordering services for pharmaceutical products being pharmaceutical preparations; business to business wholesale ordering services for medical supplies; all the aforesaid services provided exclusively between professionalsto healthcare industries and not for retail purposes
Class 42
Design and development of devices for medical use; software design; design and development of pharmaceutical products; engineering services in the pharmaceutical field; research and development services for the pharmaceutical industry; design of packaging and wrapping materials
Class 44
Medical consultation; medical clinic services
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/13/2025
FIMP
FINAL DISPOSITION PROCESSED
07/13/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/14/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/17/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/19/2024
GNRT
NON-FINAL ACTION E-MAILED
08/19/2024
CNRT
NON-FINAL ACTION WRITTEN
08/19/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/15/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/12/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/12/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/13/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/20/2023
GNFR
FINAL REFUSAL E-MAILED
11/20/2023
CNFR
FINAL REFUSAL WRITTEN
11/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/18/2023
RFNT
REFUSAL PROCESSED BY IB
06/06/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/12/2023
RFRR
REFUSAL PROCESSED BY MPU
05/12/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2023
CNRT
NON-FINAL ACTION WRITTEN
03/22/2023
DOCK
ASSIGNED TO EXAMINER
03/20/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/02/2023
Continuous trademark protection
Get notified about every new filing that threatens APTAR PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.